Open Label, Controlled, Post Marketing, Registry Study of Ribociclib (Ribo) Treatment Adherence and Patient Reported Outcomes in Participants Using ReX Technology Platform
Clinical trial NCT06344416 · RECRUITING
Trial details
- NCT number
- NCT06344416
- Sponsor
- Dosentrx Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-30
- Primary completion
- 2025-03-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.